|
CHCHD4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.739970E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.246320E-02 |
| Normal-vs-Stage2 |
4.480800E-01 |
| Normal-vs-Stage3 |
1.395350E-04 |
| Normal-vs-Stage4 |
2.211000E-04 |
| Stage1-vs-Stage2 |
1.384730E-03 |
| Stage1-vs-Stage3 |
4.322300E-02 |
| Stage1-vs-Stage4 |
6.325900E-02 |
| Stage2-vs-Stage3 |
4.49070000000384E-05 |
| Stage2-vs-Stage4 |
2.643300E-04 |
| Stage3-vs-Stage4 |
7.610000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.188500E-04 |
| Normal-vs-AfricanAmerican |
1.209700E-02 |
| Normal-vs-Asian |
2.097600E-01 |
| Caucasian-vs-AfricanAmerican |
8.469200E-01 |
| Caucasian-vs-Asian |
6.732200E-02 |
| AfricanAmerican-vs-Asian |
1.848980E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.200400E-03 |
| Normal-vs-Female |
5.935800E-03 |
| Male-vs-Female |
1.566630E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.896800E-03 |
| Normal-vs-Age(41-60Yrs) |
3.562800E-03 |
| Normal-vs-Age(61-80Yrs) |
2.651800E-02 |
| Normal-vs-Age(81-100Yrs) |
8.781800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.809400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.876400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.682600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.171400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.162800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.252000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.12469999999665E-05 |
| Classical-VS-Follicular |
1.209060E-04 |
| Classical-VS-Other |
5.557000E-01 |
| Classical-VS-Normal |
9.429700E-04 |
| Tall-VS-Follicular |
1.47570000663677E-09 |
| Tall-VS-Other |
1.997410E-01 |
| Tall-VS-Normal |
2.70300000160262E-08 |
| Follicular-VS-Other |
1.040980E-01 |
| Follicular-VS-Normal |
4.829400E-01 |
| Other-VS-Normal |
5.022200E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.835500E-02 |
| Normal-vs-N1 |
3.88620000000284E-05 |
| N0-vs-N1 |
4.439600E-03 |
|
|
